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Abstract
A technology is presented for exposing the contents of microfabricated cavities in a
substrate. These contents are hermetically sealed until exposure is triggered by an
electronic signal. The exposure mechanism uses electrothermal heating to rupture a
metal membrane at one end of the cavity. The device’s capability for storing a variety
of contents and exposing them on demand makes it well suited for periodic exposure
of new sensors as old ones degrade.
Two commercialization possibilities are investigated: biowarfare agent detection
and in vivo glucose sensing. Both applications employ sensing mechanisms that
can be miniaturized and packaged in an array. These sensors are susceptible to
fouling or degradation over time from environmental factors. The controlled-exposure
technology addresses this problem by periodically exposing fresh sensors. The two
applications are thought to be especially favorable markets because of the need for
reliable, continuous sensing.
The engineering aspects of the technology are investigated by identifying key
material properties for each component of the device. The key properties for the
substrate material are suggested to be its vapor permeability and suitability for
cavity formation. The most important properties of the membrane are its electrical
requirements (the current and voltage required to expose or “activate” the device), its
strength and hermeticity, and its stability in the intended working environment. Design
and materials selection approaches for optimizing these properties are presented.
Thesis Supervisor: Krystyn J. Van Vliet
Title: Thomas Lord Assistant Professor of Materials Science and Engineering
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Chapter 1
Introduction
Consider a “smart package”—an automated container that opens itself. It stores its
contents indefinitely in a hermetically sealed environment (Figure 1-1). It has no
moving parts, no mechanical components that might leak or clog. It is opened with
a voltage pulse, which resistively heats and ruptures a metal membrane at one end of
the container (Figure 1-2).
Multiple containers can be constructed in a batch process, and thousands could be
fabricated simultaneously on a single substrate. They can be made from biocompatible
and biostable materials for use in an implantable medical device. In fact, they could
be constructed from many possible materials depending on the constraints of the
particular application. They might be filled with any combination of circuits, sensors,
macromolecules, and cells. The containers might be opened one by one, or all at
once, or in any combination. Opened apertures allow the inward and outward flux of
particles, fluids, light, sound, and information.
Figure 1-1: Schematic of a controlled-exposure device [1].
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(a) (b)
Figure 1-2: Representative micrographs of 50µm×50µm metal membranes (a) as
fabricated and (b) after electrothermal rupture [1].
1.1 Background
This hermetic controlled-exposure concept originated in the early 1990s, when Langer
and Cima conceived of a silicon microchip that could deliver drugs automatically in
vivo [2]. Langer has recounted the origins and early development of the concept [3]:
“About 12 years ago, I was watching a television show on PBS about how
the computer industry made chips, and I started thinking that chips might
be a good way to carry out drug delivery. I called Michael J. Cima, who is
one of my colleagues and a professor of materials science and engineering
at MIT, and asked for his help in developing a way to test the idea. We
solicited the help of a student, John Santini, who began developing a drug
delivery chip first as a summer project and later for his PhD thesis. Santini
was able to create a chip prototype with tiny wells into which drugs could
be placed. These chips offered myriad delivery possibilities. The wells
might contain different doses of the same drug, or a variety of different
drugs—literally, a pharmacy on a chip.”
Santini’s microchips, shown in Figure 1-3, contained arrays of pyramidal cavities, or
reservoirs, etched in silicon. The cavities were capped with gold membranes that could
be electrochemically dissolved in saline with an applied voltage [4]. At approximately
+1V relative to a saturated calomel reference electrode, the formation of soluble gold
compounds in saline becomes thermodynamically favorable. The membranes thus
dissolve atom by atom. Santini used this mechanism to demonstrate the storage and
controlled, multiplexed release of fluorescent and radio-labeled compounds [5].
Santini considered the practical details of commercialization from the beginning,
identifying key characteristics of the device such as its capability to store and release
solids, liquids, and gels [4]. An operational space was outlined that considered both
the dosage frequency and volume. The release of steroids or hormones for drug
delivery and enzymes for immunoassays was seen to be particularly favorable because
of these compounds’ high activity. In 1999, Santini formed MicroCHIPS, Inc. (Bedford,
MA) with Cima and Langer to commercialize this electrochemical mechanism for drug
14
(a) (b)
Figure 1-3: Prototype microchips configured for the electrochemical mechanism [4].
Photographs by (a) Richard Holman and (b) Paul Horwitz (Atlantic Photo).
Figure 1-4: 1 cm×1 cm, 24-cavity microchip (front and back) configured for the
electrothermal mechanism [11].
delivery applications. Cima’s and Langer’s groups at MIT have continued to develop
and demonstrate similar devices [6–8].
An alternate controlled-exposure mechanism was later invented at MicroCHIPS by
Uhland and Polito [9]. This mechanism employs an electrothermal process: resistive
heating from an applied current ruptures the membrane in a process similar to blowing
a fuse. Operation is complete within tens of microseconds, and the typical activation
current—that is, the current required to rupture the membrane and expose the cavity—
is several amps. The electrothermal mechanism soon supplanted the electrochemical
mechanism at MicroCHIPS for several reasons. First, the electrothermal mechanism,
which is relatively energetic, is more reliable than electrochemical dissolution [10].
Second, the mechanism is independent of the surrounding medium. Third, the
mechanism is faster, operating in microseconds rather than minutes [1,6].1
An obvious concern about the electrothermal mechanism involves the amount
of heat dissipated near the membrane and the possibility of degrading the cavity
contents: the membrane is heated to its melting point during operation, and the
melting temperatures of gold and titanium are above 1000◦C. The thermal impact to
1However, the electrothermal mechanism requires orders of magnitude more current than the
electrochemical mechanism and requires the device circuitry to be redesigned. The selection of materials
to reduce operating current is addressed in Chapter 3.
15
(a) (b)
Figure 1-5: (a) Representative 100-reservoir drug delivery microchips configured for
the electrothermal mechanism; (b) Fully implantable drug delivery device used to
demonstrate peptide release over six months in an animal model [12].
the cavity contents is limited, however, because of the brief duration of activation. The
energy dissipated in the membrane area during activation can be as low as tens of
microjoules, which is barely enough to heat one microgram (one nanoliter) of water
by a temperature increase of 10◦C. This temperature increase is usually negligible,
especially because the duration of heating is brief. For the applications described in
this thesis, one microgram is a negligible amount of material even for contents that
could be degraded by a temperature increase of 10◦C.2
The electrothermal mechanism has been demonstrated in vitro and in vivo. A 24-
cavity microchip, shown in Figure 1-4, was packaged within a flow cell and used
to release periodic doses of a radio-labeled compound in vitro with a coefficient of
variation of 4% [1]. The mechanism was further demonstrated in a six-month in vivo
study in which 100 to 250µg of leuprolide was delivered weekly in beagle dogs [12].
The peptide leuprolide was chosen as a model drug; it is used in cancer treatments and
has low bioavailability when given orally. The fully implantable systems used in this
drug delivery study each contained a 100-cavity microchip, a microprocessor, a battery,
and wireless telemetry (Figure 1-5).
As of 2006, MicroCHIPS is continuing on the path to commercialization of the
electrothermal technology. The company is financed through venture capital funding
and corporate partnerships, and currently has nineteen employees. Over twenty-five
U.S. and non-U.S. patents have issued, and over fifty patent applications are pending
[13].
2It is assumed here that the specific heat and density of these contents can be modeled with
the properties of liquid water. Otherwise, the upper bound of the amount of material heated to a
temperature difference ∆T is calculated as EM/cp∆T , where EM is the energy dissipated near the
membrane, c is the material’s specific heat, and p is the material’s density.
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1.2 Thesis organization
This thesis examines a technology for controlled exposure. Commercialization of drug
and fragrance delivery by the electrochemical mechanism was the focus of a previous
thesis [14], and is not discussed further here. Rather, the focus is on the electrothermal
mechanism, which might be applied to applications other than implantable drug
delivery. The thought process for conceiving alternative applications and its conclusions
are described here, and several favorable applications are examined.
This thesis addresses engineering and commercialization aspects of the electrother-
mal mechanism. The goals are to review how the technology has been made and used,
to guide the development of new devices through engineering analysis of material
properties, and to outline favorable commercial opportunities. To that end, the
contents are arranged as follows:
§ Device fabrication and operation are addressed in Chapter 2. Two fabrication
processes are outlined for constructing silicon microchips with cavities created by
wet and dry etching processes. Operation is described by presenting experimental
results from MicroCHIPS’ prototype devices with gold membranes.
§ A materials selection process is described in Chapter 3. The most important
parameters related to the substrate and membrane are described. Modeling,
experimental results, and literature reports are used to develop guidelines for
optimizing performance.
§ The search for suitable applications and its results are described in Chapter 4.
The capabilities and limitations of the device are summarized and the area of
sensor exposure is chosen for investigation. Two favorable sensing applications,
biowarfare agent detection and in vivo glucose sensing, are described with an
overview of each field, an explanation of the technology’s benefits, and a concept
of technology integration.
§ Conclusions drawn from this work are summarized in Chapter 5.
17
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Chapter 2
Device fabrication and operation
The current state of the electrothermal mechanism is reviewed in this chapter. This
material is intended as a foundation for later chapters on materials selection and
commercialization. Two fabrication processes are presented, and device operation is
described by reviewing experimental results.
2.1 Fabrication
Briefly, controlled-exposure microchips are fabricated by depositing or growing a
dielectric layer on a silicon substrate, depositing and patterning metal circuitry and
membranes on one side, creating cavities by chemical etching from the back side,
and removing the dielectric layer from underneath the membranes. The cavities
are subsequently filled with contents for future exposure and then sealed. Santini
and Johnson have described in detail the use of MIT’s Microsystems Technology
Laboratories for fabricating microchips configured for the electrochemical mechanism
[4,10]. Many of their processes are similar to the ones described below.
It is useful first to review the major components of the microchip:
• The substrate contains the cavities and supports the circuitry. All of the
microchips configured for the electrochemical and electrothermal mechanisms
have employed single crystal silicon as a substrate, most frequently in the starting
form of four-inch wafers. Some advantages of silicon are that it is sufficiently
hermetic for chemical storage, it can withstand elevated-temperature processes
that occur at hundreds of degrees Celsius, it is easily incorporated into wafer-
based microfabrication processing lines, and it can be chemically etched with
micrometer-scale accuracy by both wet and dry methods. However, the use
of other substrate materials is certainly feasible. Materials selection issues
concerning the substrate are discussed further in Chapter 3.
• The dielectric layer electrically insulates the metal circuitry from the substrate.
This layer also provides a free-standing support for the membrane during
processes in which the creation of the cavities precedes membrane deposition.
Alternatively, the layer serves as an etch stop to protect the membrane in cases
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where the membrane is deposited before the cavities are etched. An identical
layer on the opposite side of the wafer is used as a mask during cavity etching,
and the selected dielectric material must therefore be resistant to the particular
silicon etchant used to create the cavities. Two materials have been used
so far: chemical-vapor-deposited (CVD) silicon nitride, which is resistant to
aqueous silicon etchants, and thermally grown silicon dioxide, which is resistant
to fluoride-based plasma etching of silicon. Both materials can be deposited
simultaneously on both sides on multiple wafers in a CVD or oxidation furnace.
• The traces electrically connect the membrane area with wire-bond pads at the
edge of the chip. These features desirably have a low electrical resistance to
reduce resistive losses. The resistance is minimized by using a thickness of several
microns of sputtered or evaporated gold with a 10nm titanium adhesion layer.
The traces are also designed to be as wide as possible, as shown in the chip
photograph in Figure 1-4.
• The membrane hermetically seals the cavity until exposure is triggered. In
the simplest embodiment, the membrane and traces are the same material
and a single metal layer comprises both. For efficiency reasons, however, it
is desirable to decouple the membrane material and thickness from the trace
material and thickness. It is favorable for the membrane metal to have a relatively
high resistivity to generate the maximum amount of resistive heat, a low
thermal conductivity to minimize heat loss to the substrate, and a low melting
temperature to minimize the temperature increase required for operation. The
microchips used in MicroCHIPS’ six-month animal study, for example, contained
0.3µm-thick titanium membranes with a 10 to 20 nm layer of platinum on
each side and a 10nm titanium adhesion layer. The membrane material was
predominantly titanium because of its high electrical resistivity and low thermal
conductivity compared to the gold used in the traces. The platinum provided
an inert coating on each side of the membrane. Both titanium and platinum
have higher melting temperatures than gold; however, the changes in the other
material properties were sufficient to reduce the required operational current by
at least a factor of two [1]. The selection of membrane materials is discussed
further in Chapter 3.
All of the materials in MicroCHIPS’ devices were chosen with biocompatibility in
mind, and this requirement has constrained materials selection in some cases. For
example, gold is not the lowest resistivity material that could be used for the traces;
however, gold is preferred for medical implantation over the more conductive silver and
copper. Additionally, titanium was chosen as an adhesion layer over other possibilities
such as aluminum and chromium because of the widespread use of titanium in
implantable devices.
Two general fabrication processes are presented here as a foundation for later
discussion of materials selection and technology commercialization. The first process
relies on a single wet etching step to create the cavities. Aqueous hydroxide solutions
such as potassium hydroxide (KOH) preferentially etch silicon {100} and {110}
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crystallographic planes over {111} planes with a selectivity of approximately 100:1.
A single-crystal silicon wafer with a {100}-oriented surface allows the creation of
pyramidal holes bounded by these slower-etching {111} planes. This process is
included because it was used for the experimental results described later in this
chapter; additionally, both literature reports to date of the electrothermal mechanism
feature microchips made using this first process [1, 12]. It is relatively simple: only
one etch step is involved and the etching process does not require any tools beyond
a chemical hood. Additionally, more than one wafer can be etched simultaneously in
solution, which is an advantage in manufacturing.
The second process employs deep reactive ion etching (DRIE), a method of etching
holes with straight sidewalls in silicon. DRIE is a multiplexed process in which the
wafer is exposed to two plasma chemistries that switch every few seconds. The first, a
sulfur hexafluoride chemistry, isotropically etches silicon, forming silicon tetrafluoride
as a volatile etch product. The second, a fluorocarbon gas (C4F8), dissociates in the
plasma to form a polymer layer on exposed surfaces. When the etch chemistry is
reinstated, ion bombardment removes the polymer layer on the bottom of the trench
and the wafer surface only. The polymer remains on the sidewalls, preventing lateral
etching. Through-wafer extrusions of surface mask shapes can be created by this
process.
The DRIE process presented here allows an array of openings to be constructed over
a single cavity. This technique exposes more area per cavity without the strength issues
that arise from simply increasing the membrane size. The process is presented because
it is particularly suitable for an application in which a sensor is exposed [15]. In this
case payload is not a strong constraint; rather, the primary interest is to expose a large
area to maximize flux and thus reduce the sensor response time.
Fabrication by wet etching
The first fabrication process is illustrated in Figure 2-1. In (a), a silicon wafer with a
{100}-oriented surface is coated with a 0.2µm layer of silicon-rich, low-stress silicon
nitride (SiNx) by low-pressure chemical vapor deposition (LPCVD) at approximately
800◦C. In (b), the silicon nitride is photolithographically patterned on the back side
and a cavity is created in the substrate by wet chemical etching with aqueous KOH
(25wt%, 80◦C). In (c), a titanium/gold (10 nm /2µm) layer is deposited by physical
vapor deposition and patterned to electrically connect the cavity area to wire-bond pads
at the edge of the chip. In (d), a suitable membrane material is deposited and patterned
over the suspended silicon nitride. The optimal material depends on the application;
previous devices have employed gold, titanium, platinum, gold-silicon, and composite
membranes. Finally, in (e), the silicon nitride support is etched from the back side by
plasma etching, and wire bonds are added to connect the chip to external circuitry.
Fabrication by plasma etching
The second fabrication process is illustrated in Figure 2-2. DRIE is used here with a
nested mask process, in which photolithography is used to define two separate mask
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Figure 2-1: Fabrication process in which wet anisotropic etching is used to create
cavities [11].
layers before etching is initiated. The first mask allows the etching of holes that will
later form the suspended membrane areas. After this step, the first mask is removed,
leaving the second mask defined for an additional etching step. The second etch forms
the cavity. Nested masks are especially useful for processes with multiple deep etch
steps, as it is difficult to spin-coat and expose photoresist uniformly on a wafer with
existing cavities.
In (a), a 1µm layer of silicon dioxide is thermally grown on a silicon wafer (the
crystallographic orientation of the wafer is unimportant). Silicon dioxide is resistant
to the DRIE etching chemistry with a selectivity of greater than 100:1. In (b), a
titanium/gold (10 nm /2µm) layer and a suitable membrane material are deposited
and patterned as before. In (c), the silicon dioxide layer on the back side of the wafer
is patterned as a mask for the second etch. In (d), a layer of photoresist is patterned
as a mask for the first etch. These two patterned layers comprise the nested mask
arrangement. In (e), DRIE is used to etch holes partially through the wafer in the future
suspended membrane locations. The photoresist is then removed, and a second DRIE
etch is performed in (f) using the silicon dioxide as a mask. This second etch forms
the cavity and removes the remaining silicon underneath the membranes. Finally, in
(g), the silicon dioxide layer is etched from the back side by plasma etching, and wire
bonds are attached as in the previous process.
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Figure 2-2: Fabrication process in which deep reactive ion etching (DRIE) is used to
create cavities [11].
Incorporation of cavity contents and sealing
The cavities in the fabricated device can be filled at this point for applications in which
molecules are to be released. Alternatively, an additional substrate containing sensors
can be attached. The cavity can then be sealed using any one of a number of suitable
low-temperature methods identified for the device [16]. In the six-month animal
study performed by MicroCHIPS, the cavities were sealed by thermocompression with
indium-tin solder spheres [12]. The heat dissipation during sealing was sufficiently
localized and brief to not degrade the material (leuprolide) to be released. The metal-
sphere-sealed configuration is illustrated in Figure 2-3, which also shows an attached
borosilicate glass substrate with through-wafer holes that was added to increase the
cavity volume from 120 to 300nL.
2.2 Operation
Configuration and geometry
This section addresses the operating characteristics of the electrothermal mechanism.
The microchips described here were fabricated based on the first process described
earlier, in which aqueous KOH is used to etch pyramidal cavities in the substrate. The
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Figure 2-3: Schematic of a drug delivery reservoir sealed by an indium-tin sphere
[11,12].
process employed four-inch silicon wafers with a thickness of 525µm. The membrane
size was 50µm×50µm, and the membrane material was most frequently patterned
from a sputtered 0.3µm gold layer with a titanium adhesion layer.
Membrane rupture and cavity exposure
The device operates by resistive heating as illustrated in Figure 2-4. Heating can occur
preferentially in the membrane from a combination of effects. First, the membrane
may be suspended in a medium such as water that is less thermally conductive than the
substrate (the thermal conductivity of water (0.6Wm−1 K−1) is more than two orders
of magnitude smaller than that of silicon (150Wm−1 K−1)). Second, the cross section
of the membrane may be designed to be smaller than that of the traces to increase the
local current density. A reduction in width can be seen at each membrane location in
Figure 1-4. Third, the membrane may be constructed from a material with a higher
electrical resistivity than that of the traces, increasing local resistive heat generation
[9].
In most cases, the membrane ruptures by melting and withdrawal of molten
material to the edges of the opening, where the material refreezes. This activation
mode is supported by the appearance in micrographs of rounded edges forming a bead
of refrozen material (Figure 1-2(b)). In some circumstances, the membrane appears
to rupture by a fracture mechanism, but this effect is unusual and occurs outside the
normal regime of activation [1].
Activation circuitry
An activation circuit is shown in Figure 2-5. The total circuit resistance R is divided into
three parts (membrane resistance, trace resistance, and off-chip/electronics resistance)
to aid in analysis and design. The membrane resistance RM is strongly coupled to
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(a) (b)
Figure 2-4: Conceptual illustrations of suspended membrane as fabricated and under
applied current [11].
Figure 2-5: Activation circuit for electrothermal mechanism [1].
activation behavior. Only the resistive heat generated at the membrane is useful for
activation; resistive heat in other components is unused and reduces efficiency. The
trace resistance RT represents the resistance of the metal patterns on the chip used
to address each membrane. This value depends on the trace material, width, and
thickness. The electronics resistance RE includes the series resistance of the capacitor
and switches and the resistance of all external wiring. The trace and electronics
resistances typically are each approximately 1Ω and are combined in some later
analyses as the non-membrane resistance RNM = RT+ RE.
A suitable energy source is a capacitor with capacitance C that has been charged
to a voltage V . The use of a capacitor eliminates the need for a battery to provide
ampere-level activation currents. As long as the characteristic time constant RC of the
circuit is much larger than the activation time (typically in the tens of microseconds),
the supplied voltage can be regarded as constant during activation. This condition is
not required, but it simplifies analysis and operation by ensuring that the capacitor’s
stored energy is not drained significantly during activation.
The switches could be mechanical, but better performance is achieved by using
transistors controlled through additional circuitry. Voltages that are applied after the
25
Figure 2-6: Measured activation current of a gold membrane in water [1].
circuit is broken can cause electrolysis bubbles to nucleate in the liquid surrounding the
ruptured membrane area. The characteristic time of bubble nucleation has been found
in experiments to be milliseconds or greater. It is therefore best for the activation pulse
to be timed with a duration of less than one millisecond or for the pulse to be switched
off automatically upon detection of an open circuit. The use of transistors to turn the
activation current on and off enables this precise timing.
Characterization of activation
Activation can be characterized by examining the time-dependent current (Figure 2-
6). This current is measured by placing a sense resistor—a low-resistance, precision
resistor—in series with the circuit. The voltage drop across this resistor is then
measured at a sampling rate of 1MHz and the circuit current calculated by using
Ohm’s Law. Current is a suitable parameter for characterization because it is strongly
coupled to the membrane’s behavior as it heats and ruptures. Activation voltage, in
contrast, depends not only on the membrane configuration but also on the resistance
of the traces and the off-chip circuitry, and is therefore not as useful a standard of
measurement.
To compare different configurations, an activation time is defined as shown in
Figure 2-6. The current typically rises to a maximum value, then decreases, most likely
due to the increase in membrane resistance with increased temperature and melting.
Since the current changes with time, a nominal activation current is also defined to
equal the ratio of the voltage V to the room temperature resistance R of the circuit.
This current usually corresponds to the maximum current measured by using the sense
resistor. When activation is especially rapid, however, the 1MHz sampling rate may
not be frequent enough to capture this maximum value.
Shown in Figure 2-7 are images and current measurements for gold membranes
activated in water at different currents. The suspended area was 50µm×50µm
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Figure 2-7: Light micrographs (left), scanning electron micrographs (center), and
activation currents (right) for five gold membranes (suspended area 50µm×50µm)
activated in water. The scale bar represents 50µm in all images. [1].
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(a)
(b)
Figure 2-8: (a) Activation time and (b) opening area as a function of activation current
for 50µm×50µm gold membranes activated in water [1,11].
for each membrane. The opening areas were evaluated after activation by using a
calibrated optical microscope and imaging software. Note that in Figures 2-7(d,e),
activation was too rapid for the data acquisition circuitry to identify the maximum
current, which should equal the nominal current defined above. As the applied current
increases, the activation time generally decreases and the opening size increases; these
trends are plotted in Figures 2-8(a) and (b). The preferred region of activation for
these devices is in the range of 4 to 5A, where the opening size approaches 100%. A
consistent large opening area is desirable because this parameter controls the flux of
material in or out of the cavity, which in turn affects device performance.
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Chapter 3
Materials selection
Two fabrication processes were described in the last chapter for constructing an
electrothermal, controlled-exposure device. Both processes featured almost the same
group of constituent materials: silicon substrates, gold traces, and titanium adhesion
layers. However, there is nothing mandatory about these materials; they were selected
due to constraints of biocompatibility and substrate hermeticity related to implantable
drug delivery. Other applications will have different constraints.
This chapter identifies important material properties of the electrothermal device.
The engineering aspects of each property are analyzed, and guidelines are generated
for improving performance (for example, strengthening the device or reducing the
operating current). There are always trade-offs involved in materials selection; in fact,
several of the guidelines presented here directly conflict with each other. Ultimately,
the process is one of optimization, where guidelines must be weighted according to the
needs of the particular application.
The chapter is arranged as follows: the substrate material is addressed first, and
its key properties are suggested to be its ease of fabrication (a term to be defined)
and its permeability. The membrane and traces are then analyzed together with the
help of an electrothermal model presented in Appendix A. The membrane material’s
most important properties are determined to be its melting temperature, resistivity,
thermal conductivity, strength, and hermeticity. Resistivity is also a key property of
the trace material.
An additional requirement applies to all materials and components: they must
be sufficiently stable during fabrication and operation. That is, the materials must
resist dissolution, oxidation, and any other mechanisms that would degrade device
performance. In implantable applications, the stability of exposed materials is coupled
to a related property, the biocompatibility of the device.
Although the focus here is on optimizing materials selection, there may be
alternatives to switching materials that achieve the same result. Changing certain
geometrical aspects of the device, for example, is sometimes easier than changing
materials, and these alternative options are mentioned when appropriate.
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3.1 Substrate materials selection
Ease of fabrication
The suitability of fabrication processes constrains the choice of candidate substrate
materials (metals, semiconductors, ceramics, and polymers). How should ease of
fabrication be defined, and which material properties would maximize it? It is useful
first to consider some common fabrication methods to visualize how the device might
be made for each class of material.1 For example, cavities might be created in a
metal substrate by physical methods such as punching or drilling, or the metal might
be cast or electroplated in a mold. Wet chemical etching is commonly used to etch
metal patterns that have been defined by masking layers. Other approaches such as
electrical discharge machining, electron beam machining, and laser ablation rely on
local vaporization to remove material.
Semiconductor substrates such as single-crystal silicon are commonly etched by
chemical means, and various wet and dry chemical etchants allow both isotropic and
anisotropic etching of silicon. An example of an isotropic etchant system is the nitric–
hydrofluoric acid mixture, which oxidizes the silicon surface and subsequently dissolves
the oxide. Isotropic etching tends to produce a hemispheric cavity geometry because
all directions are etched at an equal rate. In contrast, some aqueous etchants such
as potassium hydroxide are selective to certain silicon crystallographic planes. These
solutions etch anisotropically, enabling the creation of pyramidal cavities. Dry (vapor)
etching processes also come in isotropic and anisotropic flavors: xenon difluoride vapor
etches silicon isotropically, while deep reactive ion etching (DRIE) combines sequential
etching and passivation steps with ion bombardment to enable anisotropy and create
deep trenches with near-vertical sidewalls. The chemical nature of these etchants
provides relatively high selectivity and therefore allows the use of masking layers with
a thickness of several micrometers or less.
Ceramics can be fired in a mold or etched by physical or chemical mechanisms.
Physical etching approaches include ultrasonic drilling [18] and powder blasting [19],
both batch processes. Ceramics can also be etched chemically: one example is the
patterning of glass by hydrofluoric acid. DRIE has been used to etch glass, but the
etch rate is relatively small (less than 1µmmin−1) because of the relative stability of
Si–O bonds [20]. Masking generally becomes more difficult when physical methods,
severe chemicals, or ion bombardment is required. The poor selectivity of glass DRIE,
for example, limits the cavity depth to tens of micrometers even when using a metal
mask several micrometers thick.
Finally, polymer substrates have been defined by molding and stamping processes,
chemical etching, or curing in place. Mechanical approaches such as stamping would
likely place excessive stresses on a suspended membrane, but polymers can also be
etched chemically, for example by an oxygen plasma. Smigiel et al. recently reported
polymer DRIE, which may emerge as a suitable method of creating cavities [21].
Alternatively, an additive photocuring approach such as stereolithography might allow
1Madou compares the advantages and limitations of various micromachining techniques in his
textbook Fundamentals of Microfabrication [17].
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Table 3.1: Characteristics of cavity fabrication processes for different substrate material
candidates (M=metals, S= semiconductors, C= ceramics, P= polymers.)
Commonly
used for Selective Anisotropic Batch
Physical processes
Drilling, stamping M,S,C,P No Yes Some
Laser ablation M No Yes No
Powder blasting C No Yes Yes
Chemical processes
Wet etching M,S,C Yes Single crystal Yes
Dry (vapor) etching (e.g., XeF2) S Yes No Yes
Combination phys./chem.
Dry chemical etching w/ ion S Yes Yes Yes
bombardment (e.g., DRIE)
Additive
3-D printing M,C,P N/A Yes Some
Electroplating M N/A Yes Yes
Photocuring P N/A Yes Some
the substrate to be built up around the membrane.
Selected process are evaluated in Table 3.1 according to key characteristics. It is
assumed that the goal is to etch cavities in a controllable way to produce freestanding
membranes. Only a few methods described above could be reasonably expected to
accomplish this goal. Physical etching approaches such as drilling or powder blasting,
for example, are not normally capable of stopping on a membrane of sub-micrometer
thickness after removing hundreds of micrometers of substrate material. Chemical
etching, in contrast, employs a chemical reaction that creates a soluble or volatile
compound that is then removed. These reactions allow a high degree of selectivity
and are thus favorable for fabrication.
Another desirable etching characteristic is anisotropy, which enables the creation of
cavities with geometries other than hemispherical. This capability allows the creation
of customized geometry such as the silicon structure shown in Figure 2-2. A third
characteristic, batch fabrication, which allows simultaneous etching of cavities, is
favored over sequential fabrication, especially for relatively large and dense arrays
of features. Further considerations include the temperature limit of the material,
the substrate’s suitability for lithographic patterning, and the cost of the fabrication
process.
We might therefore define ease of fabrication as the ability to successfully fabricate
multiple cavities simultaneously with arbitrary geometries and capped with suspended
membranes. This parameter is most strongly coupled to the nature of the cavity
etching process (chemical vs. physical, isotropic vs. anisotropic, batch vs. sequential)
but should also take into account the additional issues (temperature limit, suitability
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Figure 3-1: Cross-sectional micrograph of a wet-etched silicon wafer anodically bonded
to a borosilicate glass wafer with powder-blasted through-wafer holes [11]. The curved
feature at the top of the micrograph is the edge of an epoxy plug used to stabilize the
region during sectioning.
for patterning, and cost) listed above.
Single-crystal silicon was likely chosen as a substrate for the original MIT prototypes
based on considerations such as these. However, it should be recognized that
alternatives exist. A single new application requirement such as optical transparency
or mechanical flexibility would force a change from silicon to another material.
The discussion above presents only the broadest look at the selection of a substrate
material. Exceptions exist to many of the evaluations given in Table 3.1, and new
materials, tools, and techniques are always being developed to solve fabrication
challenges. An example of an advanced technique is the use of combined substrate
materials. In MicroCHIPS’ six-month in vivo drug delivery study, a borosilicate glass
wafer with etched through-wafer holes was added to the original silicon substrate to
increase volume (Figure 2-3). A cross-section micrograph of this configuration is shown
in Figure 3-1. Besides increasing volume, the glass substrate offers optical transparency,
which could be useful for optical sensing applications.
Permeability
An additional constraint on candidate substrate materials is their ability to separate
cavity contents from the external physical environment. Some of the degradation
mechanisms of macromolecules such as proteins involve exposure to oxygen and water
[22,23]. The small size and high density of the cavities make it more difficult to prevent
sufficient vapor ingress to cause degradation. If the geometry and cavity contents are
fixed, the only remaining parameter to alter is the substrate material’s permeability.
The permeability P is related to diffusivity D, but also incorporates the diffusing species’
solubility S:
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P = DS (3.1)
This relationship allows transport to be estimated even if the concentration of the
diffusing species in the substrate is not known; its partial pressure in the surrounding
environment is sufficient. The units of permeability are (cm3 s−1)·(cm cm−2 atm−1),
signifying a certain material leak rate at standard temperature and pressure (cm3 s−1)
along a distance (cm) and across an area (cm2) at a certain pressure difference (atm).
The driving force for vapor ingress into a cavity is the difference in partial
pressure between the external environment and the cavity. The maximum allowable
permeability of a substrate can be estimated by considering the pressure difference, the
sensitivity of the contents (that is, the permissible vapor pressure inside the cavity), and
the cavity geometry. The relationship of interest is [24]
p =∆p0

1− exp

−PA∆p0 t
vL

(3.2)
where p is the partial pressure in the cavity after time t, ∆p0 is the original pressure
difference, and the associated geometry is cavity volume v, diffusion cross-sectional
area A, and environment-to-cavity separation length L. Note that this analysis does not
include species created by chemical reactions or desorbed from the materials inside the
cavity.
As an example calculation, consider a vacuum-sealed cavity with internal volume
v=1mm3 surrounded by other cavities open to the environment, where the partial
pressure of oxygen is 0.21 atm. We also assume a cross-sectional area A=4mm2,
a separation length L=1mm, and a maximum permissible oxygen partial pressure
p=0.01 atm. The maximum allowable permeability P is found from Equation (3.2)
to be 2×10−11 (cm3 s−1)·(cm cm−2 atm−1). This limit is beyond the capability of most
polymers. For example, nylon’s oxygen permeability at 25◦C is approximately 10−10,
polystyrene’s is 10−8, and silicone’s is greater than 10−6 in the same units [25]. For
larger cavities, longer diffusion distances, or less sensitive contents, however, a polymer
substrate may be suitable.
The diffusion coefficient of oxygen at room temperature has been reported to be
10−20 cm2 s−1 in silica [26] and orders of magnitude lower in silicon [27]. The oxygen
permeability values would be even lower because oxygen solubility in these materials
is far less than unity. Stringent permeability requirements therefore suggest the use of
silicon or glass substrates over polymer substrates. A comparison of materials and the
graphical calculation of suitable permeability for this example is shown in Figure 3-2.
These estimates of vapor permeation should be confirmed by experiment. Helium
is typically used as a model gas because of its small molecular size and its low
concentration (approximately 5 ppm) in air [24]. Helium leaks can be measured to
less than 10−9 atm cm−3 s−1 by using mass spectroscopy. However, it can be difficult to
translate the helium leak rate to a corresponding water vapor leak rate. An alternate
experiment for determining water vapor permeation is to enclose a hygroscopic
material (a desiccant, for example) in a cavity adjacent to open cavities and to immerse
the substrate in water. The water might be pressurized to accelerate the test. The
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Figure 3-2: Relationship between separation length L, substrate permeability P, and
time for oxygen intrusion to 0.01 atm (assumptions: initial pressure difference ∆p of
0.21 atm, cross-sectional area 4L2, and cavity volume L3). Data tabulated by Massey
[25].
desiccant cobalt chloride changes color when hydrated, enabling easy determination
of the amount of water absorbed. Water or oxygen permeation can also be estimated
by sealing sensitive materials such as proteins in the cavity, exposing the substrate to
the storage or operational environment for some period of time, and then removing the
materials and assaying them for activity. The advantage of this test is that it measures
the true parameter of interest: molecular degradation over time.
3.2 Membrane and trace materials selection
Activation-related properties
Several electrical parameters are related to activation: current, voltage, and energy,
for example. Which of these should be the focus during materials selection? In fact,
all of these characteristics are important at different stages of the design and testing
process. The most useful measurement while testing membranes is the current, as
it is the current density that controls the amount of resistive heating. The required
current for a particular membrane configuration is independent of the resistance of
any external circuitry, which is why the operational data in this thesis are reported
in terms of current. Circuit and device designers, however, may find voltage a more
useful value. The battery size is coupled to voltage, and the circuit components are
all rated by voltage. Additionally, the capacitor is charged to a certain voltage that
can be confirmed before activation by direct measurement. Finally, it is the amount
of dissipated energy that is most strongly coupled to the temperature increase inside
the cavity, and a primary function of the device is to ensure the stability of the cavity
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contents. Thus, all three parameters are necessary for a complete analysis.
The first few important parameters of the membrane material are related to the
electrical requirements to achieve activation. An electrothermal analysis of activation
can be found in Appendix A; this analysis addresses resistive heat generation, the
mechanisms of heat loss from the membrane, and the activation time and dissipated
energy.
The results of the analysis in Appendix A are summarized here. First, the volumetric
heat generation Qgen in the membrane is found to be
Qgen = J
2ρ =
V 2ρ
w2(ρ+ hRNM)2
(3.3)
where J is the current density, ρ is the membrane electrical resistivity, V is the
activation voltage, w is the width of the membrane feature (including the overlap
of the membrane over the substrate), h is the membrane thickness, and RNM is the
non-membrane resistance. This relationship suggests that heat generation can be
maximized by adjusting the resistivity of both the traces and the membrane. The trace
material resistivity should be minimized to reduce the non-membrane resistance as
much as possible: low-resistivity materials such as silver, copper, gold, and aluminum
are the most suitable. If the trace material is otherwise constrained, an alternative is
to increase the width or thickness of the traces or to reduce the resistance of the other
circuit components.
The membrane resistivity is optimized by selecting a value equal to hRNM to
maximize the power transfer from the energy source to the membrane. Either the
membrane material could be changed or an impurity added to the existing material
to increase resistivity. The effects of alloying on metal resistivity are shown in Figure
3-3. Resistivity in metals increases with small concentrations of an impurity, as seen
in Figure 3-3(a). Further increasing the concentration eventually again reduces the
resistivity as the impurity becomes the dominant element (Figure 3-3(b)) or as ordered
intermetallics form (Figure 3-3(c)). As alternatives to changing the material, the
resistance of the membrane might also be altered by changing its thickness or by
changing its length-to-width ratio.
The second result of Appendix A involves heat loss from the membrane, which is
desirably minimized. Heat loss is dependent in part on the temperature increase in
the membrane. For example, conduction through the membrane and conduction to
the surrounding environment are proportional to the temperature rise ∆T = T − T∞,
where T∞ is the ambient temperature. Radiative heat loss is proportional to the
difference of the fourth power of temperature (T 4 − T 4∞). Boiling is associated with
significant values of heat flux due to the energy associated with a phase change. The
next guideline is therefore to reduce the material’s melting temperature to as low a
value as possible. The melting temperatures of MicroCHIPS’ membranes are relatively
high: gold melts at approximately 1060◦C, titanium at 1670◦C. How were these
materials selected? The electrochemical mechanism used gold membranes because
gold can be electrochemically dissolved in saline, and the electrothermal concept was
first demonstrated by using microchips configured for the electrochemical method.
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(a) (b)
(c)
Figure 3-3: (a) Resistivity of aluminum-containing films as a function of alloying
element content [28], (b) Resistivity of copper-nickel films as a function of nickel
content [29], and (c) Resistivity of copper–gold films as a function of gold content [30].
Titanium membranes were later introduced by applying the guideline above addressing
membrane resistivity: titanium, whose resistivity is an order of magnitude larger
than that of gold, was selected to increase the membrane resistance RM to the same
magnitude as the non-membrane resistance RNM. Considerations of biocompatibility
also influenced the selection of both materials.
We might consider using a membrane material whose melting temperature is much
closer to ambient temperature, ideally below the boiling point of water to eliminate
boiling-related losses.2 Indium, which melts at 157◦C, is one possibility. An alloy of
indium and tin might also be used; the phase diagram of this system is shown in Figure
3-4. This system features a eutectic, a melting point lower than that of either of the
constituent metals, when the elements are combined in approximately equal parts.
2The melting temperature need not be lower than 100◦C, however, to prevent boiling. Boiling
temperatures are larger in the case of a rapid temperature increase on smooth surfaces because of the
energy penalty of nucleating a vapor bubble. The boiling temperature of water on smooth surfaces
at large heating rates has been theoretically estimated and experimentally found to be larger than
300◦C [31–33].
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Figure 3-4: Indium-tin phase diagram [29].
Alloying may also have a favorable influence on strength and hermeticity, as described
later in this chapter. Alloy deposition could be accomplished by cosputtering, in which
two separate targets are sputtered at independent power levels to enable arbitrary
film stoichiometry. Another approach is to cast an alloy target from which the film
is sputtered; this approach is well suited for the manufacturing stage after an alloy
composition is selected.
The third relation from Appendix A applies specifically in the case where heat
conduction through the membrane is the dominant mechanism of heat loss. This
situation is more likely when the membrane size (width and length) is small, the
thickness h is large, or the thermal conductivity k of the membrane material is large.
Under these conditions, the following estimate for required voltage Vreq applies:
Vreq = 2(ρ+ hRNM)
r
k∆T
ρ
(3.4)
where k is the membrane thermal conductivity and ∆T is the temperature difference
between the center and the edge of the membrane. Note that the guidelines of
optimizing ρ and reducing∆T are still valid in Equation (3.4). Additionally, a material
with a lower thermal conductivity could be used to reduce the required voltage. At a
certain point, however, the conduction term will no longer dominate and the analysis
above will no longer be valid. The membrane thickness h could also be reduced, with
the same condition that this optimization step tends to suppress the circumstances
under which it applies.
It is also important to note that electrical resistivity and thermal conductivity are
inversely related in metals. This relationship is described by the Weidemann-Franz
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Law: the ratio kρ/T is approximately equal to a constant (2.45×10−8WΩK−2). The
thermal conductivity of a metal is therefore also affected by alloying.
The fourth result from Appendix A is that lower bound of energy dissipated EM,min
is given by
EM,min ≈ 4r20hp(c∆T +Hm) (3.5)
where r0 is half the side length of the membrane, c is the membrane specific heat, p
is the membrane density, and Hm is the membrane material’s heat of melting. This
lower bound is the amount of energy needed to heat the membrane to its melting point
and to melt it. Reducing the dissipated energy toward this minimum value requires
the activation voltage and current to be increased.3 It may be advantageous in some
applications to minimize the energy in this way. So far, however, the strategy for
operation has been to use the minimum voltage that ensures consistent operation;
this strategy is driven mainly by the desire to reduce the battery size of the implantable
device in in vivo applications.
Strength
The microchip’s usefulness is compromised if the membranes are too fragile to
withstand loading conditions during fabrication, handling and shipping, and operation.
There is therefore an interest in increasing membrane strength. In general, the
membranes can withstand relatively large pressures, but are susceptible to damage
from small displacements. For example, 0.3 to 0.4µm thick, 50µm×50µm Pt/Ti/Pt
membranes have been found to be resistant to rupture at fluid pressures of up to tens
of atmospheres. A displacement of only one micrometer, however, applied near the
connection point between the membrane and the substrate would likely shear the
membrane and create a leak path.
The strength of thin films is known to depend on the thickness. For example,
Espinosa et al. found that the yield strength of evaporated gold is independent of
thickness for columnar-grained films, but drops by almost 50% for films that are more
than one or two grains thick [35]. This transition occurred at a thickness between
0.5 and 1.0µm and was attributed to the increased number of slip systems in the
thicker films. The dependence of yield strength on thickness complicates the process
of designing membranes for a particular strength. It is usually necessary during the
design process to suuplement theoretical calculations with rupture tests of actual films.
Stronger membrane materials are desirable because they would enable the success-
ful fabrication and use of larger membranes, which expose more area. However, metals
with lower melting temperatures tend to have lower yield strengths, and problems
involving membrane strength may arise with the incorporation of new membrane
materials for reduced current.
3This guideline is somewhat counterintuitive but is supported by theoretical and experimental results
(Equation (A.12) and Figure A-5, respectively). Higher currents and voltages accelerate the activation
process and reduce the concomitant heat loss from the membrane to the surrounding environment.
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Figure 3-5: Hardness and resistivity for different gold-containing alloys [34].
One approach to strengthening bulk metals is to use an alloy, and this approach
could be applied to the membrane as well. Solid solution alloying increases yield
strength because the strain field of each solute atom interacts with the dislocation strain
field and hinders dislocation motion [36]. Alloying has been demonstrated as a way
of strengthening microfabricated features. Brazzle et al., for example, strengthened
platinum flexures for micromirrors by alloying with iridium (10%) and also with
ruthenium and rhodium (6% and 15%, respectively) [37]. The features were deposited
by sputtering from a cast target. The yield stress of these alloys was determined to be
greater than 1GPa. Additionally, Lee et al. added platinum, rhodium, and ruthenium
to gold films to strengthen microscale electrical contacts and compared the hardness
and resistivity of the alloys (Figure 3-5) [34].
Membrane survival is also promoted by gentle handling: contacting the membrane
with smooth surfaces only and avoiding direct rinsing sprays. The environment in
envisioned in vitro applications is a relatively gentle sample stream that is not expected
to rupture the membranes. For in vivo applications, it is desirable to place the
membrane in contact with smooth tissue only. The best geometry seems to be multiple
smaller membranes per cavity, as described by Santini et al. [15]. Cima et al. have also
described reinforcing strips over the membrane that are intended to provide a similar
strengthening effect [38].
Hermeticity
The membrane should be sufficiently hermetic to prevent degradation of the contents
of the cavity before it is opened. Protein stability is strongly dependent on the
storage environment, especially the surrounding moisture and oxygen content [22,23].
Moisture and oxygen ingress through the membrane can occur in several ways.
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Figure 3-6: Illustration of thermal grooving and triple junctions in a suspended thin
film [43].
First, pinhole defects may appear during membrane deposition. This problem was
observed with prototypes fabricated at MIT’s Microsystems Technology Laboratories
(MTL) in which e-beam evaporation was used to deposit the membrane. Tsau at
al. independently reported the same problem at MTL after depositing gold films
for a different application; they attributed the cause to source spitting from the
evaporation crucible [39]. Pinholes have not been observed in membranes that have
been deposited by sputtering, however, and the problem of large defects has essentially
disappeared in current MicroCHIPS devices. The most likely reason is that sputtering
does not involve molten material and is not susceptible to source spitting. Additionally,
sputtering produces a conformal coating that may cover impurity particles better than
evaporation.
The second mechanism is pinhole nucleation. Surface grooves can appear in a film
along the paths where grain boundaries intersect the surface (Figure 3-6). The driving
force is the reduction of surface area [40]. The process tends to reduce film thickness;
in a suspended film, the effect occurs on both sides and can result in pinholes nucleating
at the so-called triple junctions where three grains meet.
Pinhole formation is a diffusion-related process and is strongly dependent on the
film temperature. Suspended gold films, for example, are susceptible to pinhole
formation in minutes at temperatures greater than 500◦C [4]. The self-diffusivity of
metals is roughly equal at the homologous temperature (T/Tm, where Tm is the melting
temperature) [41]. As a result, self-diffusion effects are more significant for metals with
lower melting temperatures. However, there is some evidence of grooving suppression
by alloying [42]; furthermore, small amounts of impurities are known to be capable of
suppressing recrystallization, another diffusion process [36]. Alloying may therefore
be a useful way to address pinhole formation in low-melting-temperature membrane
materials.
The third type of leak is atomic or molecular diffusion through grains or (more
likely) grain boundaries. Grain boundaries are known to be relatively easy diffusion
paths due to their increased atomic spacing. Diffusion will be strongly dependent on
the method of deposition and the nature and concentration of impurities in the films,
which will tend to segregate at grain boundaries. In practice, the helium leak rate
through suspended metal membranes has been found to be less than 10−9 atm cm−3 s−1
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[13], and this value is thought to be sufficiently low to prevent degradation in typical
controlled-exposure applications.
3.3 Selection of materials for device stability
A final requirement is that all materials should be stable in and compatible with the
intended working environment. Stability here involves the possibility of corrosion,
dissolution, or other degradation mechanisms. Compatibility involves the possibility
for degradation products to negatively impact the system.
The literature on biostability and biocompatibility is large. A general approach to
ensuring device stability it to make it thermodynamically or kinetically unfavorable for
the device to degrade. For example, the platinum coating on Pt/Ti/Pt membranes is
resistant to forming soluble complexes in liquid. The titanium would fully oxidize over
time, but oxidation is kinetically restricted both by the existing native oxide layer and
the platinum coating.
Stability can be investigated in several ways. The material or device can actually
be implanted, and this method gives the most valid results. It is also the most
expensive. The material can be immersed in a simulated physiological medium at
37◦C and examined periodically. This approach results in more uncertainty than the
implantation approach, since the medium cannot replicate complex activity such as
inflammation (although known components of the inflammation response, such as
increased hydrogen peroxide, can be added to the mixture). It also occurs in real
time. A third approach is accelerated testing, in which the activity of the degrading
medium is increased either by increasing temperature or by adding more concentrated
solutes. This technique provides data the most rapidly. A disadvantage is that other
modes of degradation might be activated that would not be expected to occur in normal
operation.
Compatibility, the impact of the material on the environment, can also be evaluated
at different levels of realism. For in vitro applications, the contents of the cavity and
the sample stream can be exposed to the device and changes in operation measured.
For in vivo applications, the device might be placed in a cell culture or implanted in an
animal to determine the degree of inflammation or to estimate the risk of more severe
responses.
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Chapter 4
Commercialization
There are multiple ways to position any new technology in the marketplace. Santini
et al.’s first prototypes, which operated by the electrochemical mechanism, were
conceived as precursors to a “pharmacy-on-a-chip,” and the focus was on controlled
release and medical implantation [5]. At MicroCHIPS, this focus has since shifted
to the more general concept of controlled exposure. Santini recently described the
electrothermal mechanism as a “smart package” that might release chemicals, expose
sensors, or both [13].
Commercialization of the electrothermal technology is investigated in this chapter.
The advantages and limitations of the technology are first reviewed, and the area
of sensor exposure is chosen for investigation. Two applications, biowarfare agent
detection and in vivo glucose sensing, involve frequent or continuous sensing, but
progress in these areas is limited by sensor lifetime. A controlled-exposure technology
would address the problem by enabling the periodic exposure of fresh sensors.
Incorporation of this technology with existing sensors could provide revenue through
a partnership with sensor companies and the sale of augmented devices.
4.1 Identifying favorable applications
Several questions are useful in identifying an appropriate application or market for a
new technology:
1. What are the capabilities and limitations of the new technology? Although it
is more common to compare concepts by their respective strengths, it is useful to
also explore the constraints and eliminate applications where the constraints are
the limiting factor. For example, the relatively small capacity (<1µL) of Santini
et al.’s controlled-release microchips has led MicroCHIPS to investigate the in
vivo release of only the most potent compounds [4].
2. In what applications is the technology necessary? However interesting or
clever the concept, success in the marketplace depends on providing an added
value sufficient to justify expense.
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3. Is the market lucrative? Alternatively, is the market prominent? The application
of any new technology desirably leads to a large revenue stream. However, a
prominent application involving a long-sought-after goal could also be favorable
if it attracts public attention and more investors.
4. How would value be extracted? A business model necessarily includes a
strategy for how money will be made when the technology is introduced into
the marketplace.
The first question, involving advantages and limitations, can be addressed immedi-
ately. The rest of this chapter addresses the remaining questions for the applications
that emerge as most favorable.
Capabilities and limitations
The electrothermal mechanism has the following general capabilities and characteris-
tics:
• Hermetic long-term storage of material in solid, liquid, or gel form.
• Large arrays of discrete cavities containing a variety of contents.
• Exposure on command of drugs, sensors, cells, or other contents, or a combina-
tion of these.
• Automated, closed-loop system regulation.
A number of limitations are apparent, however:
• Cavity contents cannot be changed after the sealing process, and the device
cannot be reused after the membranes are ruptured. Exposure is thus limited
to one-time use only; the device is not a hermetic valve.
• Membranes are individually addressed, making the device difficult to access
electrically when large arrays of cavities are fabricated.
• The instantaneous current requirement of 1 A or more is challenging to supply
in some applications such as medical implantation. The power requirements
are strongly coupled to the membrane material, which may be constrained by
strength, hermeticity, and stability requirements.
• The <1µL payload limits the number of possible dispensing applications. The
payload could be increased by increasing the substrate thickness at the cost of
increasing the required diffusion length, characteristic release time, and device
size.
• The technology at this point costs more than mature dispensing methods (such
as microsyringes) and mature manual-exposure methods (such as blister packs).
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• The food and drug administration (FDA) has not (yet) approved this technology
for use.
The drug delivery application was discussed in a previous MEng thesis [14], and is
not discussed further here. Instead, the applications addressed in this chapter involve
the controlled exposure of sensors. The packaging of sensors removes some limitations:
payload volume is no longer a significant constraint, for example. Additionally, the one-
time exposure capability is well suited for periodic exposure of fresh sensors.
It remains to be determined whether the value of storing and periodically exposing
sensors justifies the cost of incorporation. The most favorable markets are identified
by looking at applications where frequent or continuous sensing is important (for
example, for national security reasons or for avoiding health problems) but where
current sensing strategies are limited by sensor lifetime. The two areas examined here,
biowarfare agent detection and in vivo glucose sensing, were chosen to fulfill these
criteria.
Sensing mechanisms and signal generation
The second question in the commercialization checklist above concerns the need for
the technology and the most suitable uses for the mechanism. Before discussing
applications in detail, it is first useful to identify which sensing mechanisms are
appropriate for packaging in an array and exposing in a controlled manner. For
example, electrochemical sensors are well suited for miniaturization; these sensors
operate by measuring the voltage, current, or impedance between electrodes. Optical
sensors rely on a change in optical properties of a substrate, film, or fluid due to the
presence of the species of interest. One detection method, for example, consists of
measuring fluorescence intensity by photodiodes. Even though it may not be practical
to package multiple photodiodes in cavities, a single photodiode array underneath a
transparent substrate could interrogate different areas of the substrate as they are
exposed. Finally, microfabricated structures such as cantilevers or membranes may
deflect or exhibit a change in dynamic response due to surface binding of molecules.
The response can be measured electrostatically or piezoelectrically, and the whole
assembly could be packaged and controllably exposed.
The mechanisms described above are at least one step removed from actual sensing
of an analyte; they are not yet selective to the species of interest. Selectivity is enabled
by adding a molecular recognition element to the sensor. One example can be found
in the electrochemical approach of measuring lactose in vivo by amperometry. One
of the electrodes is maintained at a potential of approximately +0.7 V (vs. a Ag/AgCl
reference electrode) to oxidize hydrogen peroxide in the vicinity, and the resulting
faradaic current is measured. A layer of lactose oxidase over this electrode provides
selectivity by catalyzing the oxidation of lactose while simultaneously producing
hydrogen peroxide. Another example is the deflection of a membrane due to surface
binding of molecules. Selectivity is achieved here by coating the membrane with bound
antibody molecules that have an affinity to one particular antigen that (in theory) will
then be detected over all others.
45
Why is it necessary to periodically expose fresh sensors? A common limitation is
that the molecules and layers that provide selectivity are susceptible to degradation.
For example, enzyme proteins may degrade in the presence of oxygen, hydrogen
peroxide, water vapor, or other environmental factors. Additionally, the sensor may be
fouled with background or contaminant material, blocking the detection of the analyte
of interest. The outcome of these degradation phenomena is a general need for periodic
exposure of new sensor surfaces.
4.2 Biowarfare agent detection
One commercialization strategy is to select candidate markets in which continuous
sensing would be valuable but is currently impossible or impractical. The first area of
interest is the exposure of sensors for biowarfare agent detection. Continuous sensing is
desirable in this area for public health and national security reasons but is challenging
because of sensor lifetime limitations.
A 2003 National Defense University report describes the motivation behind detec-
tion:
The 21st century opened with the startling use of anthrax spread deliberately
through the United States mail system, resulting in 5 dead, at least 17 infected,
and more than 30,000 on preventative antibiotics. It also led to substantial
disruptions in normal activities, the revision of long-standing procedures, and
the expenditure of several billion dollars for decontamination efforts. At present,
the intelligence community assesses that “approximately” a dozen states maintain
offensive [biowarfare] programs and that interest among particular subnational
organizations is high. . .Protecting United States forces, facilities, and civilians
at home and abroad from biological weapons is a pressing national priority.
[44] (emphasis added)
Biowarfare agents can consist of bacteria, toxins, or viruses. The Centers for Disease
Control (CDC) classifies these agents as follows (Table 4.1):
[Category A diseases/agents] include organisms that pose a risk to national
security because they can be easily disseminated or transmitted from person to
person, result in high mortality rates and have the potential for major public
health impact, might cause public panic and social disruption, and require special
action for public health preparedness. [Category B diseases/agents] include
those that are moderately easy to disseminate, result in moderate morbidity rates
and low mortality rates, and require specific enhancements of CDC’s diagnostic
capacity and enhanced disease surveillance. [Category C diseases/agents] include
emerging pathogens that could be engineered for mass dissemination in the future
because of availability, ease of production and dissemination, and potential for
high morbidity and mortality rates and major health impact. [45]
Methods of detecting toxic warfare agents include tools such as mass spectrometry,
polymerase chain reaction (PCR), and antibody- and enzyme-based sensing. The
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Table 4.1: Centers for Disease Control (CDC) list and classification of biological threat
agents [45,46]. Agent type: B= bacterium, T= toxin, V= virus.
Disease (organism) Agent type
Category A
Anthrax (Bacillus anthracis) B
Botulism (Clostridium botulinum toxin) T
Plague (Yersinia pestis) B
Smallpox (variola major) V
Tularemia (Francisella tularensis) B
Viral hemorrhagic fevers (filoviruses [e.g., Ebola and Marburg] V
and arenaviruses [e.g., Lassa and Machupo])
Category B
Brucellosis (Brucella species) B
Epsilon toxin (from Clostridium perfringens) T
Food safety threats (e.g., Salmonella species, Escherichia coli B
O157:H7, Shigella)
Glanders (Burkholderia mallei) B
Melioidosis (Burkholderia pseudomallei) B
Psittacosis (Chlamydia psittaci) B
Q fever (Coxiella burnetii) B
Ricin toxin (from Ricinus communis [castor beans]) T
Staphylococcal enterotoxin B T
Typhus fever (Rickettsia prowazekii) B
Viral encephalitis (alphaviruses such as Venezuelan equine V
encephalitis, eastern/western equine encephalitis)
Water safety threats (e.g., Vibrio cholerae, Cryptosporidium parvum) B
Category C
Emerging infectious diseases such as Nipah virus and hantavirus V
characteristics and use of these tools have been reviewed by Paddle [47], Iqbal et
al. [48], Lim et al. [49], and Gooding [50]. This section focuses on one specific
class of sensor as an exemplary candidate for packaging and exposure: optical sensors
employing antibodies for molecular recognition. There are several advantages to
this selection. First, multiple surface areas with bound antibodies can be selectively
exposed and interrogated by optical components. Second, optical sensors may be cheap
enough that multiple devices (each including an array of packaged surfaces) could be
manufactured for distributed or handheld sensing. This concept has been described in
a 2004 report by the National Research Council of the National Academies:
Chemical sensors are versatile and available in many configurations that can be
small in size, rapid in reporting information, and low in cost. If such sensors could
be made reliable enough and cheap enough, it might be possible to use them as
biological “smoke detectors” and distribute them widely throughout a building or
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other target that needs to be protected. When highly distributed, they are likely to
be closer to any potential release and hence experience a still larger concentration
of agent, thereby possibly lessening the stringent demands on discriminating an
agent from the ambient background. It is this interplay of highly distributed and
cheaper but simpler sensors that offers an intriguing trade space. [46]
Third, antibody-based optical sensors are already in use, and it should be possible
to package antibody arrays without significant modification. This ease of integration
makes a partnership with a sensor manufacturer more practical from a business
perspective than if it were necessary to develop and characterize a new sensing
mechanism.
Optical antibody-based detection
Antibody-based sensors rely on molecular recognition and binding between antibodies
(which are provided with the sensor) and antigens (which are sensed in the sample
stream). These sensors provide relatively high sensitivity (parts per billion or better
[50]). Along with this sensitivity, however, comes a problem of reversibility. Since
molecular binding is so favored thermodynamically that unbinding is rare, sensors
cannot be re-used and usable sensor lifetime is limited. This factor motivates the
use of a controlled-exposure mechanism: the more irreversible the reaction, the more
sensitive the sensor, and also the more necessary the controlled-exposure capability for
periodically exposing new sensor surfaces.
Some relevant optical sensors demonstrated in the literature are listed here.
The following devices are candidates for integration with a controlled-exposure
mechanism:
• The Autonomous Pathogen Detection System (APDS) was developed at Lawrence
Livermore National Laboratories for detection of biowarfare agents [51, 52].
An aerosol cyclone collector first transports particles into a liquid sample.1
The system then periodically performs an antibody-based assay and initiates
polymerase chain reaction (PCR) amplification if an analyte of interest is
detected. A flow chart for operation is shown in Figure 4-1(a). The device
was reported to operate for seven days, performing 154 assays. A number of
pathogens, including Bacillus anthracis, Yersinia pestis, Bacillus globigii (a Bacillus
anthracis simulant), and botulinum toxoid (inactivated botulinum toxin) were
successfully detected (Figure 4-1(b,c)) [52].
1Sample collection is a complicating factor when detecting harmful particles in air. Bacterial spores
are not associated with any significant vapor pressure, and it is necessary to sample large quantities of air
(several hundred liters or more) per diagnostic step. Collection methods have been developed to convert
these spores into a liquid environment [53]. For example, cyclone samplers and virtual impactors are
two tools that operate by an inertial mechanism, in which particles are separated by size and diverted
into a liquid. Another approach is bubbling, in which aerosols are sprayed into a liquid, which is then
assayed. Particle collection devices may also incorporate a trigger that checks particle sizes and initiates
a sensing sequence if a significant increase in particle count is detected.
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(a)
(b) (c)
Figure 4-1: (a) Flow chart for Autonomous Pathogen Detection System operation; (b,c)
Antibody-based detection of anthrax (Ba=Bacillus anthracis) and plague (Yp=Yersinia
pestis) (MFI=median fluorescence intensity) [52].
• Naimushin et al. attached an antibody-based sensor to an aircraft acting as
a surrogate unmanned aerial vehicle [54]. The device employed a detection
mechanism known as surface plasmon resonance (SPR), which is described later
in this chapter. Ovalbumin and horseradish peroxidase acted as biowarfare agent
simulants, and samples were collected by a gravity droplet collector. The sensor
successfully detected the analytes.
• Rubina et al. demonstrated the detection of several of the agents in Table 4.1
(anthrax, ricin, and staphylococcal enterotoxin B) on a single substrate by using
a fluorescence immunoassay (Figure 4-2) [55].
The devices described above demonstrate that optical antibody-based assays are
available for detecting the CDC’s species of interest and that detection is feasible in
real applications such as airborne detection of particles. Additionally, multiple analytes
can be detected on a single substrate. However, a significant challenge involves the
usable lifetime of sensor surfaces. The 2004 National Academies report emphasizes the
difficulty with sensor surface replacement or regeneration in continuous monitoring:
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Figure 4-2: Antibody-based detection of multiple biowarfare agents on a single
substrate developed by Rubina et al. [55].
For continuous use of a sensor, [the sensor surface must be regenerated] at the
end of an analysis. This is sometimes achieved by changing the wash conditions to
disrupt the interaction between the target and the molecular recognition element.
The stringent washing must remove bound target and nonspecifically bound
materials but leave the molecular recognition element unaffected. Renewal of
the sensor surface is typically only possible for a limited number of cycles,
after which time the sensor surface must be replaced due to degradation. [46]
(emphasis added)
The same report discusses the need to expose new sensor surfaces:
Two important considerations for extended sensor operation and environmen-
tal monitoring are reversibility of the binding interaction and surface fouling. . .
[H]arsh conditions can affect the quality of the interactive surface and therefore
limit the lifetime of the sensor. . . Surface fouling can result in false positive signals
or completely destroy the operation of the sensor by interfering with analyte-
sensing surface interactions, giving false negative signals. . . If continuous or
periodic monitoring over extended periods of time is desired, it is often
necessary to engineer the sensor system to produce a new sensing surface
automatically for each measurement, or to replace the sensing surface
periodically as surface fouling occurs. [46] (emphasis added)
These comments indicate that there is sufficient motivation to integrate a sensor
device that can be fabricated in an array configuration with a technology for controlled
exposure.
Integration of controlled-exposure technology
A concept for controlled exposure of an optical sensor is illustrated in Figure 4-3. This
particular sensor operates by surface plasmon resonance (SPR), the mechanism used
by Naimushin et al. for airborne detection [54]. An SPR sensor detects a molecular
binding event by reflecting light off of a thin metal film on which antibodies are
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Figure 4-3: Schematic of multiple antibody-coated surfaces exposed by the
electrothermal mechanism and optically monitored. The sensor exposed first (left) may
not detect the analyte of interest due to fouling from adsorbed or deposited background
molecules. The newly exposed sensor (right) successfully detects the analyte.
bound. The technology is described in a North American Technology and Industrial
Base Organization report:
SPR is a quantum effect arising from the interaction of light reflecting from a
metal surface. Under certain conditions, the energy carried by photons of light is
transferred to packets of electrons, called plasmons, on a metal surface. Energy
transfer occurs only at a specific resonance wavelength of the incident light, and
the resultant effect is absorption of the light at this resonance wavelength. The
SPR resonance wavelength is determined by three factors: the metal, the structure
of the metal’s surface, and the nature of the medium in contact with the metal’s
surface. The plasmon’s electric field extends about 100 to 200 nanometers in a
direction perpendicular to the metal surface. Any change in the material within
the plasmon’s field causes a change in the resonant wavelength (i.e., resonance
wavelength shift). The practical consequence of this extended electric field is that
the SPR effect can directly monitor antibody–antigen binding when the antibodies
are coated on the metal surface. No tag molecule is required to detect the binding
event. Further, the amount of resonant wavelength shift, SPR shift, is proportional
to the amount of binding that takes place. A capture antibody is immobilized on
the metal surface. The antigen (analyte) binds to the antibody, and this binding
event is read by the instrument as a SPR shift. [53]
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An advantage of SPR sensing is that it does not require repeated washing steps:
in theory, the sensor operates without maintenance until a positive signal is detected.
However, non-specific binding may eventually degrade the sensor surface. In Figure
4-3, this fouling has rendered the first open sensor (left) ineffective. A newly opened
sensor (right) is capable of detecting the presence of analyte of interest when it enters
the sample stream. This concept could be applied to the substrates demonstrated by
Rubina et al. or Hindsen et al. to enable a long-term, multi-analyte detector. This
detector might be used where long-term, automated operation is desired, such as with
unmanned aerial vehicles or distributed biowarfare agent “smoke detectors.”
The ability to hermetically store and controllably release another group’s sensors
could result in better reliability, extended lifetime, and new sensing strategies that
involve closed-loop exposure of different sensor surfaces. The most appropriate
markets are those that involve high-importance sensing with infrequent inspection or
maintenance.
One possible business model is to partner with a sensor company with an existing
line of biowarfare or toxic agent detectors. This company would also sell the product
and pay a negotiated licensing fee based on sales to the holder of the controlled-
exposure patents. An alternative approach is to license the use of a sensor that has
been developed at an academic or corporate research lab and to develop and sell an
integrated device independently. In either case, the potential customers would include
the military (whose interest is in reliable portable detection), government security
agencies (monitoring of events such as inaugurations and economic summits [56]),
and corporations or building owners (monitoring of facilities).
4.3 In vivo glucose sensing
The second application of interest is in vivo glucose sensing and the possibility of
integrating the controlled-exposure technology with an implantable sensor. There are
several appealing aspects to this application. First, the mechanism can be integrated
in its current form with little additional development, as it is already designed for in
vivo use. Second, the mechanism allows a significant improvement in the state of the
art: sensor lifetime is limited by degradation, and the storage and periodic exposure
of sensors could address this problem. Third, the market is large. Tens of millions
of Americans have diabetes, and approximately one million more are diagnosed each
year. A percentage of these patients require frequent glucose sensing to guide insulin
delivery, and the market for glucose sensing is in the billions of dollars [57].
Overview of diabetes and glucose sensing
What advances would the technology enable in the marketplace? To answer this
question, it is necessary to outline the diabetes problem and describe current glucose
sensor technology.
Diabetes is a metabolic disorder, an inability to maintain a normal blood glucose
level [58]. Patients with diabetes have a problem producing insulin, a hormone
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(a) (b)
Figure 4-4: Comparison of (a) occasional and (b) continuous glucose measurement
[59].
normally secreted by the pancreas. Insulin mediates the transfer of glucose from the
bloodstream to cells, and a deficiency of insulin causes an increase in blood glucose
levels (hyperglycemia) that is physiologically harmful. The problem is managed by
monitoring blood glucose levels and self-administering insulin when needed.
Blood glucose is most commonly checked by finger sticking—puncturing the skin
to produce a small amount of blood and applying it to a diagnostic strip. A normal
glucose level is approximately 100mgdL−1; higher levels are handled by injecting
insulin through a syringe or pump. However, occasional finger stick checks can miss
excursions outside normal glucose levels, as illustrated in Figure 4-4. A ten-year clinical
study of 1,441 volunteers showed that “keeping blood glucose levels as close to normal
as possible slows the onset and progression of eye, kidney, and nerve diseases caused
by diabetes” [58]. Blood glucose testing four or more times a day was an essential part
of the recommended management protocol.
The health advantages identified by this study and others have prompted research
into continuous sensing. Aside from a cure, the best way of managing diabetes would
be what has been termed an “artificial pancreas”—a closed-loop system that would
monitor blood glucose and deliver insulin whenever needed by a fully implantable
or transcutaneous insulin pump. However, development of such a system has been
difficult, in part due to the limitations of implantable glucose sensors.
The application analysis that follows focuses on one particular sensing mechanism:
amperometric enzyme-based sensing, the most common approach. Alternate glucose
measurement methods could represent competition if they are reliable and less
invasive. However, no such device has been demonstrated to the standards of enzyme
sensing. An example is the Glucowatch Biographer, a wristwatch-type device that
operates by reverse iontophoresis [59]. However, users report that the device “burns”
during operation and frequently stops working, for example during periods of excess
perspiration (one user commented, “I put the watch on my outer arm, and I swear it
feels like I’m getting burned. I’ve been able to tolerate it, but it is very uncomfortable.”)
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Figure 4-5: Schematic of enzyme-based amperometric glucose sensor with additional
layers to block interferents and resist in vivo fouling [65].
[60, 61]. The company has acknowledged that skin irritation is a problem and now
plans to switch to a microneedle array [62]. Other glucose measurement approaches
include infrared spectroscopy, thermal radiation, ultrasonic skin poration, glucose-
sensitive contact lenses, and tattooable fluorescent beads [62–64]. However, none
of these devices has proved as reliable as blood or interstitial fluid testing, and these
noninvasive approaches are currently limited to secondary diagnostic roles.
Amperometric enzyme-based sensing
Nearly all implantable glucose sensors rely on an enzyme-based amperometric mech-
anism [65]. The enzyme, glucose oxidase, catalyzes the oxidation of the glucose
molecule to form hydrogen peroxide and gluconic acid. The hydrogen peroxide is
then oxidized by an electrode at approximately +0.7 V (vs. Ag/AgCl) to form oxygen
and water. The oxidization process at the electrode produces a current that, in
theory, corresponds to the blood glucose concentration. This sensor can be used
subcutaneously, as the concentration of glucose in interstitial fluid tracks with the
concentration in blood with a time delay of several minutes.
A limitation to this design is that the voltage used to oxidize hydrogen peroxide also
oxidizes other molecules. For example, acetaminophen and ascorbate (vitamin C) are
also electroactive at 0.7 V [66]. A semipermeable membrane is therefore added over
the electrode that favors the diffusion of the smaller hydrogen peroxide molecule. A
suitable membrane material is a composite of cellulose acetate and Nafion, a sulfonated
copolymer [67].
A second limitation is that the relatively low oxygen levels in physiological fluid
threaten to make the enzyme-catalyzed reaction oxygen-limited instead of glucose-
limited. An additional surrounding semipermeable membrane is necessary to promote
oxygen diffusion over glucose diffusion [65]. This membrane adds an additional
time delay but ensures that the oxidation current is proportional only to glucose
concentration. An illustration of a sensor design with both inner and outer membranes
is shown in Figure 4-5.
A third limitation is that the enzyme membrane is susceptible to fouling from
macrophages, proteins, and protein fragments [68]. The oxygen-permeable outer
membrane therefore handles an additional duty, that of protecting the enzyme from
in vivo attack. Even with a barrier layer, however, the enzyme degrades over time
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Figure 4-6: Schematic of multiple enzyme-based glucose sensors exposed by
the electrothermal mechanism. The sensor exposed first (left) shows decreased
amperometric current due to enzyme degradation over time. The newly exposed sensor
(right) provides more reliable data.
[69]. The typical usable lifetime is several weeks, and this duration has an important
effect on device use [70]. Because the sensor lifetime is too short for full surgical
implantation and removal to be practical, the sensor must be inserted transcutaneously
with an electrical connection to an external monitor. The FDA limits transcutaneous
insertion to 72 hours because of the risk of infection. Consequently, each sensor can
only be used for three days before it must be discarded.
Integration of controlled-exposure technology
The electrothermal mechanism could be integrated with this glucose sensor, and the
combination of these technologies would enable a long-term device consisting of
multiple short-term sensors [71]. A conceptual view is shown in Figure 4-6. After
the enzyme on the first sensor (left) degrades beyond usefulness, an additional sensor
(right) is exposed by microprocessor control to provide continued measurements.
The envisioned fully implantable device would contain sensors packaged in con-
trolled-exposure cavities, a microprocessor, a telemetry antenna, and a battery, all
contained within a titanium housing. With a sufficient number of hermetically sealed
sensors, the implanted device could operate on the order of a year before surgical
removal and replacement.
Enzymes are susceptible to degradation even if hermetically sealed, and glucose
oxidase crosslinked with glutaraldehyde has a half-life of approximately ninety days
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in the absence of glucose [69]. This time period is longer than if the sensor were
exposed, but is still small considering the goal of implantation for at least one year.
One possible solution to use an order of magnitude more enzyme than is needed for
signal detection and to calibrate the device with the finger-stick method when each
new sensor is exposed.
A low-melting-temperature material could be used for the membrane, as described
in Chapter 3, if the material were sufficiently stable in vivo. This change could reduce
the required voltage and therefore the required battery size—a favorable change for an
implantable device.
Market value
What is the market for an implantable, continuous glucose sensor? It is helpful
to identify the expected customer population and the current costs of glucose
measurement. The number of expected buyers is smaller than the total diabetes
population, since not all patients are frequent testers. Spurgeon et al. suggest that the
expected early adopters of continuous glucose sensing devices are insulin pump users
(200,000 in U.S.), patients with “brittle” or unstable diabetes (number unknown),
patients unable to detect hypoglycemia (number unknown), children with diabetes
(200,000), pregnant women (140,000-150,000), and technocrats (number unknown)
[72].
A caveat when estimating the number of potential customers is that the fully
implantable device would require a more invasive insertion procedure than the current
transcutaneous needles. The needles are currently patient-inserted, while the long-
term device would be implanted surgically. Still, the subcutaneous implantation proce-
dure could be done on an outpatient basis and would only be required approximately
once per year. The benefits of reduced finger stick testing (to a calibration frequency
only) and continuous glucose data could convince many patients to undergo the
procedure.
It is clear that a reliable continuous glucose sensor has long been desired by
patients. Their anticipations and concerns are expressed in dozens of online weblogs
[73]:
Continuous monitor lust. They’re starting to hit the market en force, but
still aren’t quite affordable or practical. . . And now MiniMed’s new first-ever
combo pump/continuous monitor system (Paradigm REAL-Time) looks pretty darn
exciting, but still runs high ($1,000 on top of pump price, plus ?? [sic] sensor
costs), and is still not covered by insurance. In short, waiting IMPATIENTLY for
new technology to come to my aid here. Old story, new (im)patient. [74]
OK here’s the bad news [on augmenting an insulin pump with a 3-day
continuous glucose sensor]: The total cost of the upgrade is $1100.00. Yeah,
ouch. . .I have it on good authority that insurance companies (mine included, and
I checked months ago) are covering the cost of the sensor purchase. Sweet. They
are not, however, covering the cost of the Transmitter itself, even with a new
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pump purchase. Sour. . .I’ve got some serious raging hormones on for this sucker.
No more human pincushion. No more testing twelve times a day, sometimes 15.
Sometimes 20. And still managing to miss trends, knowing there’s something there
that I’m sure I’m JUST NOT GETTING. No more waking up five times during the
damn night once a month just to make sure I’m not missing something, like a
Hypo. Quicker reaction time. BG results Every Five Minutes. [75]
[From an early user of the Medtronic Guardian 3-day continuous glucose monitor]
Today I didn’t have to worry about my blood sugar. The Guardian is worrying
about it for me. If it goes too high she’ll tell me. If it goes too low she’ll tell me. So
today I could focus my mind on my work, not on my diabetes. What a gift!. . .So
do I like it? Absolutely. Is it worth what it has cost me? Double absolutely. Would
I do it again? Triple absolutely. [76]
Particularly evident in the comments above is the potential buyers’ concern about
cost.2 Both patients and device companies have a strong interest in insurance company
reimbursement. Reimbursement is judged to be cost effective if the health advantages
(quantified as “quality-adjusted life years”) outweigh the management costs. The
current Blue Cross policy is to reimburse expenses for cases in which frequent glucose
testing is medically necessary:
Use of invasive subcutaneous or noninvasive continuous interstitial glucose
monitoring devices (i.e., Minimed Continuous Glucose Monitoring System [CGMS]
or the GlucoWatch Biographer) adjunct to standard care are considered medically
necessary in the care of patients with Type 1 diabetes, when all of the following
criteria are met:
1. Inadequate glycemic control despite compliance with frequent self-monitor-
ing (at least four times per day) and including fasting hyperglycemia
(>150mgdL−1) or . . . episodes of severe hypoglycemia (<50mgdL−1). This
poor control is in spite of compliance with multiple alterations in self-
monitoring and insulin administration regimens to optimize care; and
2. Insulin injections are required 3 or more times per day or an insulin pump is
used for maintenance of blood sugar control; and
3. Four or more fingersticks are required per day. [78]
These criteria correspond to most of the patient population described above, with
the exception of the technocrats (who may be willing to purchase the device out-of-
pocket). As a reference, Medicare approved reimbursement of Medtronic Minimed’s 3-
day transcutaneous sensor four years after the FDA approved it for use and presumably
after the device had been clearly demonstrated to be useful [79].
The New England Health Institute calculated that the ratio of cost to benefit for
continuous glucose sensing was approximately $51,000 per quality-adjusted life year
2The cost of strips and meters for frequent testers is approximately $5,000 per year per patient
[64, 77]. These expenses represent a majority of the total market for self-monitoring of blood glucose,
estimated to be $5 billion per year [57].
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[72]. Amounts less than $100,000 per quality-adjusted life year are generally thought
to be favorable in the U.S. [72]. This study estimated that the continuous sensor would
cost twice the amount of strips, or approximately $10,000 per year.
The use of twice the cost of strips is, in fact, a good estimate of the cost of the
envisioned implant—without yet including the controlled-exposure device. Most of the
components (medical device battery, titanium housing, microprocessor, and telemetry)
are identical to those used in pacemakers, which cost approximately $10,000 [80,81].
The current transcutaneous enzyme-based glucose sensors, packaged independently,
cost $35 each, a small fraction of the total cost of the other implant components.
The cost of the controlled-exposure microchip is proprietary to MicroCHIPS, but the
information above allows an estimate on the order of $10,000 for the maximum
feasible cost: if the cost of integrating the microchip is smaller than this approximate
amount, then the market is favorable. The total implant price would be estimated
to be $10,000–$20,000, implying a revenue on the order of $1 billion for every
round of implants purchased by a patient population of 100,000. If the microchip
integration cost is more than this approximate amount—that is, the complete implant
cost is more than $20,000 per year per patient—then the benefit-to-cost ratio is
not favorable according to the New England Health Institute’s study, and insurance
company reimbursement is less likely.
One possible business model is to partner with a medical device company that
already has an implantable glucose sensor and experience in acquiring FDA approval.
The device company would manage the FDA approval process, sell the product, and
pay a negotiated licensing fee based on sales to the holder of the controlled-exposure
patents.
Candidates for partnership include any company developing an implantable glucose
sensor. A suitable company would need to have the resources to pursue the project
through pre-clinical and clinical tests, the FDA approval process, and the time to
acquire customers and insurance reimbursement.
It is impossible to guarantee that a noninvasive method of measuring blood glucose
will not emerge in the next few years, making an implantable device undesirable in
comparison. However, the methods attempted so far have been limited by signal
interference and other difficulties in obtaining accurate readings. The (albeit invasive)
enzyme-based sensor has been proved in vivo, as has the electrothermal mechanism.
There is therefore a clear path to assembling a reliable device that satisfies patients at
a cost acceptable to health care companies.
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Chapter 5
Conclusions
The goal of this thesis has been to present the engineering and commercial aspects
of an electrothermal controlled-exposure technology. The identification and analysis
of key material properties has enabled materials selection guidelines to be generated.
Additionally, favorable commercial opportunities were identified by considering the
capabilities and limitations of the technology.
An electrothermal analysis of activation was found to be useful for identifying
significant mechanisms of heat loss and developing guidelines for suppressing them.
The observation that heat conduction through the membrane is a dominant mechanism
of heat loss, for example, motivates the reduction of the membrane’s thermal
conductivity and thickness. In almost every case, however, approaches for optimizing
materials and geometry tend to invalidate the conditions under which they are valid.
That is, if optimization is successful, than the dominant heat transfer mechanism
will be suppressed and the corresponding guidelines will no longer apply. The one
exception is the membrane’s melting temperature: it is always advantageous in terms
of the activation requirements to reduce this value. However, a reduction in melting
temperature could lead to problems with pinhole formation and mechanical yielding
because the homologous temperature (the ratio of operating temperature to melting
temperature) of the membrane material will increase.
The use of an alloy as a membrane material could have multiple benefits: the
introduction of impurities tends to increase a metal’s electrical resistivity and reduce its
thermal conductivity, which should increase heat generation and reduce thermal losses,
respectively. Additionally, solid solutions of impurities suppress dislocation and grain
boundary motion, which could favorably affect membrane strength and resistance
to thermal grooving. Finally, some alloy systems contain eutectics, which would
further reduce the required activation temperature of the membrane. Different alloy
compositions could be tested by depositing the membrane material by cosputtering
and evaluating the activation requirements, strength, hermeticity, and stability of the
resulting devices.
A potential area of commercialization for the electrothermal technology is sensor
exposure. The most suitable types of sensors are devices that are easily miniaturized
and placed in arrays for periodic exposure. In particular, electrodes and optically
interrogated surfaces are well suited for this type of packaging. Macromolecules such as
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enzymes and antibodies enable selectivity and sensitivity; however, these compounds
are susceptible to fouling and degradation over time. The controlled storage and
exposure of these sensors would improve the state of the art in the areas of biowarfare
agent detection and in vivo glucose sensing.
The electrothermal technology has already been shown to work in vitro and in
vivo. Furthermore, the electrochemical and optical sensors discussed in this thesis have
been well characterized and widely used; one of their most significant disadvantages is
their limited lifetime. The remaining challenge is to integrate the controlled-exposure
method with these sensors at a reasonable cost and to begin bringing devices to market.
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Appendix A
Electrothermal modeling
A heat transfer model is presented in this appendix for analyzing a suspended
membrane undergoing resistive heating. A comprehensive study of membrane rupture
is beyond the scope of this thesis; activation combines multiple thermal and mechanical
effects, and even activation in air involves intricacies such as non-uniform heat
generation, a solid-to-liquid phase change, and a moving interface. When activation
occurs in liquid, an additional liquid-to-vapor phase change adds to the complexity.
A variety of heat transfer mechanisms can influence activation, including conduction
through the membrane, conduction and convection in the surrounding environment,
radiation, and boiling. An analytical solution that incorporates all of these effects does
not likely exist.
The approach that follows is limited to comparing the influence of heat transfer
mechanisms and identifying whether any one of them dominates. It may then be
possible to model some thermal aspects of activation by examining only this dominant
mechanism. Some simplifying assumptions, such as temperature independence of
material properties, are made. Furthermore, estimates of heat transfer values are
limited to order-of-magnitude precision. The model is applied to several membrane
configurations, and the predictions are found to match experimental results closely
enough to be useful in directing design efforts. The equations developed in this
appendix are used in Chapter 3 to guide materials selection for the membrane and
traces.
A.1 Governing heat transfer equation
The approach taken here is to construct a governing equation of heat transfer, then to
remove negligible terms and to simplify the equation until it can be solved analytically.
Consider a square suspended membrane with thickness h, thermal conductivity k,
specific heat c, density p, and electrical resistivity ρ. We assume that the temperature
variation across the membrane thickness is negligible because the membrane length
and width are at least two orders of magnitude larger than the thickness. The governing
equation can be written by performing an energy balance at an arbitrary point on the
membrane, as shown in Figure A-1, and dividing by the element volume h · dx · d y:
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Figure A-1: Energy balance for a differential element in a suspended membrane.
∇ · [k∇T (x , y, t)]− Q
h
+ J2ρ = cp
∂ T (x , y, t)
∂ t
(A.1)
In this equation, T is the temperature, Q = Qfront +Qback is the total heat flux to
the surrounding medium from the top and bottom faces of the membrane, and J is
the current density. The first term, which contains the Laplacian of the temperature
distribution, is related to heat conduction through the membrane; the second, heat
loss from the membrane faces; the third, heat generation; and the fourth, heat
storage. Note that, in the most general case, the material properties are dependent
on temperature, the current density is not uniform within the membrane, and the heat
flux losses are different on the front and back sides of the membrane.
This equation can be simplified by assuming temperature-independent material
properties and by approximating the spatial differential term with a finite difference
term. The simplified equation is
k
−∆T (t)
r20
− Q
h
+ J2ρ = cp
d∆T (t)
d t
(A.2)
where ∆T is the temperature difference between the center and the edge of the
membrane and r0 is a characteristic dimension, taken to be half the side length for a
square membrane.1 The minus sign appears in the first term because we are subtracting
a temperature at positive x , y from a temperature at the center of the membrane
(x = y = 0).
1Other characteristic dimensions might also be used: half the diagonal of the membrane, for example,
or the radius of a circle with equivalent area. A case could be made for using r0 = 35µm, half the
total width of the membrane (including the overlap over the substrate). As shown in Figure 2-7, the
substrate overlap areas of gold membranes melt during activation, so these regions are certainly affected
by membrane heating. In any case, the differences are negligible for this order-of-magnitude analysis.
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Figure A-2: Efficiency as a function of the ratio between membrane and non-membrane
resistances, plotted on linear and logarithmic scales.
Maximizing heat generation
It is advantageous to maximize the volumetric heat generation Qgen in the membrane
for a given activation voltage. This heat generation is measured in Wm−3 and for
resistive heating is equivalent to J2ρ. This term can be expanded as follows:
Qgen = J
2ρ =

V
whR
2
ρ =
V 2ρ
w2h2(RM+ RNM)2
=
V 2ρ
w2(ρ+ hRNM)2
(A.3)
where w is the width of the membrane feature including the substrate overlap. The
other parameters (voltage V , total circuit resistance R, membrane resistance RM, and
non-membrane resistance RNM) remain as defined in Chapter 2. It is assumed that the
membrane feature is square and that the resistivity is uniform to obtain RM = ρ/h.
The relationship suggests the existence of an optimal value of resistivity, since
current is inversely related to membrane resistance. For small values of ρ approaching
zero, the heat generation in the membrane approaches zero. Alternatively, for very
large values of ρ, the current becomes negligible, and the heat generation term
again approaches zero. The arrangement that maximizes volumetric heat generation
(acquired by setting
∂Qgen
∂ ρ
equal to zero) occurs at ρ = hRNM, where the membrane
resistance equals the non-membrane resistance. This point corresponds to the optimal
power matching between the power source (the battery or capacitor) and the intended
power sink (the membrane). The relationship between the resistances and the heat
generation efficiency is shown in Figure A-2, in which the ratio is plotted on both
linear and logarithmic scales.
A.2 Identifying a dominant heat transfer mode
A single heat transfer mechanism (conduction through the membrane, conduction to
the surrounding medium, radiation, or boiling) may have considerably more influence
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Table A.1: Properties of selected membrane and surrounding medium materials (taken
at 25◦C except for heat of melting, which is taken at the melting temperature.)
Thermal Melting Heat of
conductivity k Specific heat c Density p Resistivity temp. melting Hm
Material (Wm−1 K−1) (J kg−1 K−1) (kgm−3) ρ (nΩm) Tm (◦C) (kJ kg−1)
Gold 320 130 19100 22 1064 64
Titanium 20 520 4500 420 1668 296
Water 0.6 4200 1000
Air 0.03 1000 1.2
than the others, which can then be neglected. As a practical example, MicroCHIPS
has prototyped square 50µm×50µm gold membranes with a thickness of 0.6µm and
electrothermally ruptured these membranes in air and water. This configuration serves
as a good model for comparing the different mechanisms of heat transfer related to
air and water immersion and evaluating the case of one dominant mechanism (in this
case, membrane conduction).
Conduction through the membrane
It is assumed that a sufficient current is applied to heat at least a portion of the gold
membrane to the melting temperature. An order-of-magnitude estimate of the first
term in Equation (A.2) can be acquired by using the material properties of bulk gold
at room temperature (Table A.1) and by taking ∆T to be the difference between
the melting temperature and room temperature. With r0=25µm, the membrane
conduction term k∆T/r20 is estimated to be between 10
14 and 1015 Wm−3.
Conduction to the surrounding medium
The surrounding medium is taken to be air (the value of Q/h in the case of water
immersion is addressed below). Heat conduction to the surrounding medium can be
estimated by assuming a semi-infinite medium on both sides of the membrane. The
heat flux from each side at time t is [82]
∆T
r
kmcmpm
pit
(A.4)
where km, cm, and pm are the thermal conductivity, specific heat, and density of the
surrounding medium, respectively. The average value Qmed/h from both sides during
the activation time tact is therefore
Qmed
h
=
2
tacth
∫ tact
0
∆T
r
kmcmpm
pit
d t =
4∆T
h
È
kmcmpm
pitact
(A.5)
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Material properties of air are given in Table A.1. Assuming an activation pulse
length of 10 to 100µs (as is typically observed in experiments), this term is estimated
to be between 1012 and 1013Wm−3, roughly two orders of magnitude less than
conduction through the membrane.
Radiation exchange with the surrounding medium
The magnitude of radiation transfer from both sides of the membrane is estimated
by [82]
Qrad
h
=
2σ
h
 
T 4− T 4∞

(A.6)
where σ is the Stefan-Boltzmann constant (5.67×10−8Wm−2 K−4) and T∞ is the
ambient temperature. The surface emissivity is assumed to be unity on both sides of
the membrane. The maximum radiation transfer value, assuming a uniform membrane
temperature of 1064◦C, is estimated to be between 1011 and 1012Wm−3. This is
roughly three orders of magnitude less than the membrane conduction value.
Boiling heat transfer
The surrounding medium is now taken to be water. Vapor bubbles observed by high-
speed photography indicate that boiling does occur as the membrane electrothermally
heats and ruptures in water. The magnitude of heat flux to assign to this mechanism
is uncertain, however. Literature indicate that for a temperature difference of 1000◦C,
the steady-state boiling heat flux, which includes conduction and radiation effects, can
be as high as approximately 106Wm−2 from each side of the membrane (Figure A-
3). This corresponds to a Q/h value between 1012 and 1013Wm−3. However, higher
instantaneous values of boiling heat flux (some as large as hundreds of Wm−2) have
also been reported for suspended platinum wires [32, 83] and microscale resistive
heaters [84, 85]. The theoretical upper limit of heat flux in a vaporization process
has been predicted to be 223Wm−2 [86, 87], which would result in a Q/h value of
larger than 1014Wm−3. The range of possible estimates for boiling heat transfer is
therefore several orders of magnitude, with the maximum value in the same order of
magnitude as that of membrane conduction.
Membrane heat conduction as a dominant mode
It is estimated from the calculations above that conduction through the membrane is
the primary mode of heat loss for this particular configuration except when considering
the highest available estimates of boiling heat flux. For conduction-dominated
operation, the temperature distribution in the membrane is expected to be a strong
function of the distance to the edge of the substrate. It is also expected that the melted
area would originate at the center of the membrane and grow larger with increased
current. This effect has indeed been observed in gold membranes tested in air and
water.
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Figure A-3: Boiling heat flux and regimes in water as a function of excess temperature
[82].
The simplified version of Equation (A.2), considering only membrane heat conduc-
tion, is
−k∆T (t)
r20
+ J2ρ = cp
d∆T (t)
d t
(A.7)
whose solution provides the time-dependent temperature at the center of the mem-
brane:
∆T (t) =
J2ρr2o
k

1− exp(−tk/cpr20)

(A.8)
The minimum required current and voltage to heat the center of the membrane to
its melting temperature are calculated from Equation (A.8) to be:
Ireq = 2r0hJ = 2h
r
k∆T
ρ
(A.9)
Vreq = IreqR= 2h(RM+ RNM)
r
k∆T
ρ
= 2(ρ+ hRNM)
r
k∆T
ρ
(A.10)
The minimum required current for a 0.6µm-thick, 50µm×50µm gold membrane
is estimated from Equation (A.9) to be 4A. The actual minimum current was found
to be 5.7A in both air and water, confirming that boiling and conduction to the
surrounding medium have a negligible influence on operation for this particular
configuration. The predicted and measured minimum current values are in good
agreement considering the simplifications that were made (temperature-independent
material properties, differentials approximated by finite differences, and an approxi-
mated characteristic dimension of half the membrane side length).
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The characteristic size r0 does not appear in the current estimate in Equation (A.9),
suggesting that membrane size does not have a strong effect on the required
current. This prediction has also been confirmed in experiments: a 0.6µm-thick,
100µm×100µm membrane required 6A to open in air and 7.3A in water. This is
a relatively small current increase considering that the membrane area has increased
fourfold. Note that the activation currents are different in air and water for this
configuration. As the membrane size is increased, the membrane conduction term
(which scales with r−20 ) correspondingly decreases until this term no longer dominates.
Finally, a similar dependence on membrane resistivity is seen in Equation (A.10)
that was seen in Equation (A.3). Either a very small or very large resistivity value leads
to a large current and voltage requirement, and an optimal point must lie somewhere
in between. An additional subtlety is that for metals the thermal conductivity k is
coupled (inversely) to resistivity ρ and will also vary with materials substitution.
Membrane heat conduction as a non-dominant mode
The relationships derived above assume that heat loss is dominated by conduction
through the membrane. Configurations in which this is not the case are subject to
other governing equations, and these equations are more difficult to derive due to
nonlinear relationships between temperature and heat flow, particularly in the case
of radiation and boiling. We can at least note that the other methods of heat loss—
conduction to the surrounding medium, radiation, and boiling—all involve heat flux
normal to the membrane. If one of these mechanisms were to dominate, we would
expect little temperature variation across the membrane and melting to occur more or
less uniformly at a threshold current level.
It would be interesting to examine the behavior of a membrane for which boiling
is the dominant method of heat loss. The most prominent experimental feature would
be a required current for operation in liquid that is far higher than the required
current for operation in air. However, MicroCHIPS has not yet prototyped such a
membrane configuration. The closest example may be Pt/Ti/Pt membranes with
a titanium thickness of 0.3µm.2 Activation tests of this configuration resulted in
noticeably different current requirements when the membranes were immersed fully or
partially in water or immersed in air. The current-activation time relationships for this
configuration are shown in Figure A-4. The different results for different surrounding
media indicate that membrane conduction no longer dominates over all of the other
terms in Equation (A.2), as it did for the 0.6µm-thick gold configuration considered
earlier. The change is likely due to the change in material (the thermal conductivity of
titanium is less than one tenth of the thermal conductivity of gold, as shown in Table
A.1), and the reduction of the membrane thickness.
2These membranes were coated with a 10 to 20 nm platinum layer on both sides to suppress titanium
oxidation.
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Figure A-4: Opening area as a function of activation current for a 0.34µm-thick,
50µm×50µm Pt/Ti/Pt membrane immersed in air, air/water, and water [11].
Activation energy, time, and thermal impact
Let us again consider membrane configurations in which membrane conduction is the
dominant heat transfer mode. From Equation (A.8), the activation time tact and energy
dissipated near the membrane EM are estimated to scale as
tact ∝ ln

1− I
2
req
I2

(A.11)
EM = I
2RM tact ∝ I2RM ln

1− I
2
req
I2

(A.12)
These relationships are shown graphically in Figure A-5(a), where the excess
activation current is defined to be the ratio of I to Ireq. At I < Ireq, the current is too
low to rupture the membrane in any reasonable time, and activation does not occur. At
I > Ireq, activation occurs in a finite time and dissipates some finite amount of energy.
The time and energy values both decrease with increasing current; the time approaches
zero, while the energy approaches the minimum amount needed to heat the membrane
alone to its melting temperature and to melt it. This minimum energy can be written
as
EM,min = 4r
2
0h
∫ Tm
T∞
cp dT + 4r20hpHm ≈ 4r20hp(c∆T +Hm) (A.13)
where Tm is the melting temperature, Hm is the heat of melting for the membrane
material, and the last (approximate) term assumes temperature-independent specific
heat and density. This value is the lower bound for the energy required for the
electrothermal mechanism. We can estimate this lower bound using the properties
given in Table A.1, assuming constant specific heat and density. For 0.3µm-thick,
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(a)
(b)
(c)
Figure A-5: Activation time and energy dissipated near the membrane for (a)
theoretical case and (b,c) experimental results of 50µm×50µm gold and Pt/Ti/Pt
membranes, respectively, activated in water [11].
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50µm×50µm membranes, the energy is 1.8+ 0.9 = 2.7µJ for gold and 2.9+ 1.0 =
3.9µJ for titanium. The first number in each case represents the energy need to heat
the membrane to its melting point, and the second represents the energy required for
melting.
Experimental measurements of activation time and dissipated membrane energy
as a function of current are shown in Figure A-5(b) and (c) for 0.3µm-thick,
50µm×50µm gold and Pt/Ti/Pt membranes, respectively. The activation times were
measured by observing the current traces as shown in Figure 2-6. This energy is
calculated by integrating the power generation within the membrane:
EM =
∫
I2RM d t =
∫
(V I − I2RNM) d t ≈
∑
∆t(V I − I2RNM) (A.14)
The membrane resistance RM varies with temperature and is not specifically
measured over time. However, the integrand can be rewritten as the difference
between the total energy and the energy dissipated in the traces and electronics
[1]. The non-membrane resistance RNM, which includes the traces and electronics,
is constant and known, and the current I is measured over time as shown in Figure 2-
6. The integral is approximated by summing the data points in Figure 2-6, where the
sampling interval ∆t is 1µs.
The results are at least qualitatively similar; at large current values, activation takes
between 10 and 20µs for gold membranes and just a few microseconds for Pt/Ti/Pt
membranes. Below a certain current value, activation does not occur within over one
hundred microseconds.
Two important points should be noted. First, the activation time in practice does
not asymptotically approach zero but rather the time for the membrane to physically
rupture. It appears from Figures A-5(b) and (c) that this rupture time is not greater
than approximately 15µs for gold membranes or 5µs for Pt/Ti/Pt membranes. Second,
the actual energy is always greater than the theoretical minimum energy, for several
reasons. The temperature distribution is not perfectly uniform, as is assumed in
Equation (A.13). Additionally, some energy is dissipated at the areas of substrate
overlap and during the rupture period; these additional factors are not considered
in Equation (A.13). Finally, the minimum energy point can only be approached
asymptotically at large currents and short time scales.
It is useful when evaluating thermal effects to consider the energy EM dissipated
in the membrane area during activation. The energy dissipated near the membrane
is roughly 40 to 60µJ for both gold and Pt/Ti/Pt membranes. This value is barely
enough to heat one microgram (one nanoliter) of water by a temperature increase of
10◦C. Assuming that the cavity contents can be modeled with the properties of liquid
water, this temperature increase coupled to this amount of material—both values being
upper bounds—is negligible for all applications considered so far.
A.3 Summary of electrothermal model
The analysis described above leads to the following conclusions:
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• Heat generation is maximized at a given voltage by minimizing the non-
membrane resistance and by designing a membrane with resistance equal to the
remaining non-membrane resistance. This approach provides the optimal power
transfer from the energy source to the membrane.
• The heat transfer analysis is simplified by comparing the magnitude of heat
transfer mechanisms, even to order-of-magnitude resolution, and by ignoring
the smaller terms. Membrane activation experiments support the validity of
this simplification in the case where conduction through the membrane is the
dominant mechanism of heat loss.
• In cases in which heat conduction through the membrane dominates, the
required voltage can be reduced by using a thinner membrane or a membrane
material with a smaller thermal conductivity. These changes, however, tend to
reduce the chance that heat conduction through the membrane will continue to
dominate.
• A higher instantaneous current results in faster operation and reduces the amount
of energy dissipated near the membrane asymptotically to a lower limit. This
lower limit is always larger than the energy required to heat and melt the
membrane alone with no external losses.
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